Quantcast
Connect with us

Licensing deal to boost HIV drug access

Published

on

US pharmaceutical giant Gilead Sciences and an NGO called the Medicines Patent Pool announced a deal on Tuesday aimed at boosting access to HIV drugs in poorer countries through generic manufacturing.

The HIV medicines tenofovir and emtricitabine, as well as two drugs that are still in clinical development, cobicistat and elvitegravir, will be made in low-cost copycat form under the licensing agreement.

ADVERTISEMENT

Included too is a combination of these drugs in a hoped-for single pill known as the Quad.

The Medicines Patent Pool, founded by AIDS campaign group UNITAID in 2010, seeks to widen access to HIV drugs through voluntary licences with Big Pharma.

The new deal is unusual because pharmaceutical companies very rarely allow licensing of drugs for public health while the product is still in clinical development.

“Today marks a milestone in managing patents for public health. The licence agreement with Gilead Sciences will help make medicines available at a lower cost and in easier-to-use formulations without delays,” said Ellen ‘t Hoen, executive director of the Medicines Patent Pool.

ADVERTISEMENT

“(…) People in developing countries often have to wait for years before they can access new health technologies. Today’s agreement changed that.”

Gilead will pick up royalties of three to five percent of generic sales, but will waive royalties for any formulations of the drug that are used for children.

Generic drugs have been essential in the effort to cast a lifeline to the millions of people in poor countries who are badly infected by the human immunodeficiency virus (HIV).

ADVERTISEMENT

Thanks to generics, the cost of the least expensive first-generation HIV treatment has dropped to less than $86 a patient annually from $10,000 in 2000.

However, doctors need alternatives to these front-line drugs because some patients fail to respond to the treatment. In addition, the AIDS virus mutates, posing a long-term resistance problem.

It is the first agreement between the Medicine Patents Pool and a pharmaceutical company.

ADVERTISEMENT

UNITAID, headed by former French foreign minister Philippe Douste-Blazy, was set up in September 2006 to boost funding to fight AIDS, tuberculosis and malaria. Its funding derives from a solidarity levy on airline tickets sold in 15 countries.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

In extreme crises, conservatism can turn to fascism. Here’s how that might play out

Published

on

5 movie "Back to the Future," Marty McFly (played by Michael J. Fox) travels in a time machine from the 1980s to the 1950s. When he tells people of the '50s he is from the '80s, he is met with skepticism.

1950s person: Then tell me, future boy, who's President of the United States in 1985?

This article first appeared at Salon.com.Marty McFly: Ronald Reagan.

1950s person: Ronald Reagan? The actor? [chuckles in disbelief] Then who's vice president? Jerry Lewis [comedian]?

Continue Reading

Breaking Banner

Body language expert dissects the power dynamic at play in the iconic Nancy Pelosi photo

Published

on

Last week, President Donald Trump met with Democrats at the White House to discuss the way both sides could work to fix the President's mistakes in Syria. Democrats left the White House saying that the President had another meltdown during the meeting, which prompted Trump to claim Speaker Nancy Pelosi (D-CA) was the one who had a meltdown. He then posted photos of Pelosi sitting quietly and another photo of Pelosi standing and pointing at him.

Body language expert Dr. Jack Brown posted the photo and gave his own analysis of what he believed was happening in the photo.

"When a person has little or no empathy — and/or when they're far from their emotional baseline, their ability to interpret how others will view an event becomes dramatically distorted," Brown explained Sunday. "Rarely has this behavioral axiom been better exemplified than last Wednesday at the White House."

Continue Reading
 

Breaking Banner

Internet cracks up at possible fake Mitt Romney Twitter account — and wants him to ‘run against Trump as Pierre Delecto’

Published

on

UPDATE: Sen. Mitt Romney (R-UT) has confessed to the account being his. When an Atlantic reporter called to ask for comment and ask if he was the account, Romney replied, "C'est moi."

Slate reporter Ashley Feinberg wrote that she may have discovered a secret Mitt Romney Twitter account under the name Pierre Delecto.

Continue Reading
 
 
Help Raw Story Uncover Injustice. Join Raw Story Investigates for $1 and go ad-free.
close-image